DANA PENIK: Open Payments
NPI 1184021750 · GLENVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 17 payments from 13 companies in 2025. Trend: 2023 $446 · 2024 $17 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $58 |
| Renalytix AI, Inc. | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Lilly USA, LLC | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Verona Pharma, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
Products named: KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, OTEZLA, JOURNAVX, ZEPBOUND, GARDASIL 9, XIFAXAN, PREVNAR 20, Wegovy.
Industry payments across NY — which companies pay providers there.
